Clinical and laboratory characteristics at diagnosis and after completion of 24-dose MDT (post-MDT index re-evaluation). od Andrea Maia Fernandes de Araújo Fonseca (10333122)

“...<p>Clinical and laboratory characteristics at diagnosis and after completion of 24-dose MDT (post-MDT index re-evaluation)....”

Overlap of clinical domains among patients with paired Simplified Neurological Assessment (SNA) at the post-MDT index visit (n = 99). od Andrea Maia Fernandes de Araújo Fonseca (10333122)

Table 2_Survival strategies of mycoplasmas: the critical role of post-translational modifications.docx od Tingting Li (10553)

Teme: “...Clinical Microbiology...”

Table 1_Survival strategies of mycoplasmas: the critical role of post-translational modifications.docx od Tingting Li (10553)

Teme: “...Clinical Microbiology...”

Table 3_Survival strategies of mycoplasmas: the critical role of post-translational modifications.docx od Tingting Li (10553)

Teme: “...Clinical Microbiology...”

Data Sheet 1_Impact of individualized and structured aerobic exercise on clinical outcomes in pediatric congenital heart diseases with post-surgical rehabilitation: a meta-analysis.docx od Ayoola Awosika (22687004)

Socio-demographic and clinical characteristics. od Andrea Maia Fernandes de Araújo Fonseca (10333122)

“...Known resistance mutations were identified in 2/88 patients (2.27%). Clinically, 89/131 patients (67.94%) no longer exhibited skin lesions post-MDT; however, neurological impairment increased from 70/131 (53.44%) at diagnosis to 114/131 (87.02%) at discharge. ...”

<b>Supporting data for "</b><b>Development and Characterization of Organoid-based Neutralization Platform for Predicting SARS-CoV-2 Antibody Efficacy</b><b>"</b> od Zhixin Wan (13191015)

Table 1_Red-light photobiomodulation improves cognition and neuropsychiatric symptoms in post-stroke cognitive impairment: a randomized trial.docx od Xuerong Huang (20555663)

“...</p>Conclusions<p>RL therapy may improve clinical symptoms in post-stroke patients by modulating FA metabolism, suggesting a safe and promising approach for treatment and rehabilitation....”

Efficacy and safety of Ivarmacitinib in moderate-to-severe atopic dermatitis patients with or without previous systemic treatments: a post-hoc analysis of a phase III trial od Qingchun Diao (5751701)

“...</p> <p>This study aimed to explore the efficacy and safety of Ivarmacitinib (SHR0302) in moderate-to-severe AD patients with or without previous systemic treatments.</p> <p>This was a post-hoc analysis of a phase III clinical trial of Ivarmacitinib in moderate-to-severe AD (NCT04875169). ...”

Table 1_Immune responses in pulmonary sarcoidosis following COVID-19.docx od Anna Starshinova (22571846)

A sample of DSDS spleen dataset: (a) Raw image; (b) Ground truth (spleen region is indicated as green color); (c) 3D display. od Mehmet Zahid Genc (22683526)

Teme:

The architecture of the SVNC-Net. od Mehmet Zahid Genc (22683526)

Teme:

Impacts of pruning and quantization on the model performances. od Mehmet Zahid Genc (22683526)

Teme:

Qualitative comparison of spleen segmentation results on the MSD dataset: (a) Input CT slice, (b) Ground Truth (red boundary), (c) UPerNet prediction, (d) EMANet prediction, (e) CC... od Mehmet Zahid Genc (22683526)

Teme:

Segmentation accuracy of the models. od Mehmet Zahid Genc (22683526)

Teme:

The process of standard convolution and depthwise separable convolution. od Mehmet Zahid Genc (22683526)

Teme:

Training and implementation details. od Mehmet Zahid Genc (22683526)

Teme:

A sample of MSD spleen dataset: (a) Raw image; (b) Ground truth (spleen region is indicated as green color); (c) 3D display. od Mehmet Zahid Genc (22683526)

Teme:

Qualitative comparison of spleen segmentation results on the DSDS: (a) Input CT slice, (b) Ground Truth (red boundary), (c) UPerNet prediction, (d) EMANet prediction, (e) CCNet pre... od Mehmet Zahid Genc (22683526)

Teme: